Published on 29 May 2024 on Benzinga via AOL
On Tuesday, AstraZeneca Plc (NASDAQ:AZN) said the survival results did not reach statistical significance in the overall trial population in the...
Start tracking your investments with Statfolio
You're probably familiar with the old adage, "April showers bring May flowers." And you probably ...
On Thursday, AstraZeneca PLC (NASDAQ:LON:AZN) shares received an updated price target from a mark...
AstraZeneca (NASDAQ: AZN), recognized as the world's sixth-largest pharmaceutical entity by marke...
(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have ...
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug Tuesday, ...
AstraZeneca AZN reported overall survival (OS) data from a late-stage study, which evaluated its ...
AstraZeneca (NASDAQ: AZN) is embarking on a fresh business plan that will see it grow significant...
As two of the world's largest and most prolific drugmakers, Pfizer (NYSE: PFE) and AstraZeneca (N...
On Tuesday, AstraZeneca Plc (NASDAQ:AZN) said the survival results did not reach statistical sign...
Why Is AstraZeneca Stock Trading Lower On Tuesday? On Tuesday, AstraZeneca Plc (NASDAQ:AZN) said ...